NASDAQ:NRC National Research (NRC) Stock Forecast, Price & News $43.92 -0.98 (-2.18%) (As of 06/1/2023 ET) Add Compare Share Share Today's Range$43.70▼$45.0050-Day Range$40.78▼$45.4552-Week Range$33.10▼$47.60Volume31,300 shsAverage Volume29,584 shsMarket Capitalization$1.08 billionP/E Ratio36.30Dividend Yield1.09%Price TargetN/A ProfileProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media National Research MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.07% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.25Based on 3 Articles This WeekInsider TradingSelling Shares$2.85 M Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.25 out of 5 starsBusiness Services Sector273rd out of 684 stocksCommercial Physical Research Industry17th out of 32 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for National Research. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.07% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in National Research has recently decreased by 7.34%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldNational Research pays a meaningful dividend of 1.10%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 39.67%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NRC. Previous Next 1.8 News and Social Media Coverage News SentimentNational Research has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.40 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 3 news articles for National Research this week, compared to 2 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Research insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,850,073.00 in company stock.Percentage Held by InsidersOnly 2.00% of the stock of National Research is held by insiders.Percentage Held by Institutions68.04% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 36.30, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.91.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 36.30, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 330.95.Price to Book Value per Share RatioNational Research has a P/B Ratio of 14.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About National Research (NASDAQ:NRC) StockNational Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.Read More Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Email Address NRC Stock News HeadlinesMay 31, 2023 | finance.yahoo.comNRC Health partners with ICD as lead sponsor of 7th Annual Patient Experience SymposiumMay 29, 2023 | finance.yahoo.comAre National Research Corporation's (NASDAQ:NRC) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?June 2, 2023 | Edge On The Street (Ad)Is Graphite the New Lithium?Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.May 23, 2023 | news.yahoo.comSurvey says: Confidence falls in county governmentMay 22, 2023 | msn.comNational Research Corp: Economic Earnings, Capital Productivity StandoutMay 19, 2023 | msn.comPSB Speakers: a brief historyMay 17, 2023 | chron.comProposal would give Connecticut oversight of nuclear materials used in medicine, researchMay 15, 2023 | finance.yahoo.comCMC-Canada's Management Advisory Service (MAS) program celebrates 20 years of providing essential support to Canadian businessesJune 2, 2023 | Edge On The Street (Ad)The Real Problem With "Made in America" LithiumPoliticians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple. May 13, 2023 | benzinga.comAirMatrix Secures Support to Enhance Cellular Signal Mapping up to 1,000 FeetMay 12, 2023 | finance.yahoo.comUCHealth Partners with NRC Health to Improve Healthcare ExperiencesMay 5, 2023 | msn.comAn election under the shadow of hatred in India’s KarnatakaMay 4, 2023 | benzinga.comAirMatrix receives federal funding from NRC IRAP-Canada to advance Cellular signal mapping from 400 up to 1,000 feetMay 2, 2023 | finance.yahoo.comNational Research Corporation Announces First Quarter 2023 ResultsMay 2, 2023 | finance.yahoo.comNational Research Corporation Announces First Quarter 2023 ResultsMay 2, 2023 | finance.yahoo.comPlurilock Receives Funding from the Government of Canada for Research of New Behavioural Biometric TechniquesApril 28, 2023 | americanbankingnews.comNational Research Co. (NASDAQ:NRC) Major Shareholder Sells $18,028.00 in StockApril 27, 2023 | msn.comHow to Upgrade Your Dog's Bland Kibble on a Budget, According to an ExpertApril 27, 2023 | americanbankingnews.comAmandla Mk Trust Sells 900 Shares of National Research Co. (NASDAQ:NRC) StockApril 25, 2023 | americanbankingnews.comNational Research (NRC) Scheduled to Post Earnings on TuesdayApril 18, 2023 | finance.yahoo.comNational Research Corporation to Broadcast its 2023 First Quarter Conference Call Live on the InternetApril 13, 2023 | msn.comFormer state NRC coordinator to face probe for alleged irregularities: Assam CMApril 10, 2023 | msn.comLenient Rules for Biotech Research Put the World at Risk. Will AI Do the Same?April 7, 2023 | americanbankingnews.comInsider Selling: National Research Co. (NASDAQ:NRC) COO Sells 17,643 Shares of StockApril 6, 2023 | finance.yahoo.comNRC Health reveals 2023 Pediatric Experience PerspectiveApril 5, 2023 | americanbankingnews.comNational Research Co. (NASDAQ:NRC) COO Jona S. Raasch Sells 6,288 SharesApril 3, 2023 | americanbankingnews.comCritical Review: National Research (NASDAQ:NRC) versus Data Knights Acquisition (NASDAQ:DKDCA)See More Headlines NRC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NRC Company Calendar Last Earnings2/11/2020Ex-Dividend for 4/14 Dividend3/30/2023Dividend Payable4/14/2023Today6/01/2023Ex-Dividend for 7/14 Dividend6/29/2023Dividend Payable7/14/2023Next Earnings (Estimated)8/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:NRC CUSIPN/A CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees511Year Founded1981Profitability EPS (Most Recent Fiscal Year)$1.21 Trailing P/E Ratio36.30 Forward P/E RatioN/A P/E GrowthN/ANet Income$31.80 million Net Margins20.20% Pretax Margin27.00% Return on Equity42.71% Return on Assets22.56% Debt Debt-to-Equity Ratio0.22 Current Ratio1.25 Quick Ratio1.25 Sales & Book Value Annual Sales$151.57 million Price / Sales7.13 Cash Flow$1.51 per share Price / Cash Flow29.11 Book Value$3.03 per share Price / Book14.50Miscellaneous Outstanding Shares24,610,000Free Float24,118,000Market Cap$1.08 billion OptionableNot Optionable Beta0.51 Social Links Key ExecutivesMichael D. HaysPresident, Chief Executive Officer & DirectorJona S. RaaschChief Operating OfficerKevin R. KarasCFO, Secretary, Treasurer & Senior Vice PresidentHelen L HrdyChief Growth OfficerJon BoumsteinChief Delivery OfficerKey CompetitorsSomaLogicNASDAQ:SLGCLuna InnovationsNASDAQ:LUNAMontrose Environmental GroupNYSE:MEGYextNYSE:YEXTAmplitudeNASDAQ:AMPLView All CompetitorsInsiders & InstitutionsLegato Capital Management LLCBought 4,735 shares on 5/25/2023Ownership: 0.019%Amandla Mk TrustSold 29,000 sharesTotal: $1.31 M ($45.00/share)Ameriprise Financial Inc.Bought 14,503 shares on 5/22/2023Ownership: 0.222%JPMorgan Chase & Co.Bought 3,501 shares on 5/18/2023Ownership: 0.074%New York State Common Retirement FundSold 2,000 shares on 5/18/2023Ownership: 0.037%View All Insider TransactionsView All Institutional Transactions NRC Stock - Frequently Asked Questions How have NRC shares performed in 2023? National Research's stock was trading at $37.30 at the beginning of 2023. Since then, NRC stock has increased by 17.7% and is now trading at $43.92. View the best growth stocks for 2023 here. When is National Research's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023. View our NRC earnings forecast. How were National Research's earnings last quarter? National Research Co. (NASDAQ:NRC) posted its quarterly earnings results on Tuesday, February, 11th. The company reported $0.34 EPS for the quarter. The company had revenue of $32.62 million for the quarter. National Research had a trailing twelve-month return on equity of 42.71% and a net margin of 20.20%. How often does National Research pay dividends? What is the dividend yield for National Research? National Research declared a quarterly dividend on Thursday, May 25th. Shareholders of record on Friday, June 30th will be paid a dividend of $0.12 per share on Friday, July 14th. This represents a $0.48 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend is Thursday, June 29th. Read our dividend analysis for NRC. What ETFs hold National Research's stock? ETFs with the largest weight of National Research (NASDAQ:NRC) stock in their portfolio include Royce Quant Small-Cap Quality Value ETF (SQLV), Hartford Multifactor Small Cap ETF (ROSC), VictoryShares US Discovery Enhanced Volatility Wtd ETF (CSF), SPDR S&P Health Care Services ETF (XHS), Timothy Plan US Small Cap Core ETF (TPSC), iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), WisdomTree U.S. SmallCap Quality Dividend Growth Fund (DGRS) and Is National Research a good dividend stock? National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.10%. The dividend payout ratio is 39.67%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for NRC. What is Michael D. Hays' approval rating as National Research's CEO? 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD). What is National Research's stock symbol? National Research trades on the NASDAQ under the ticker symbol "NRC." Who are National Research's major shareholders? National Research's stock is owned by a variety of retail and institutional investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (13.05%), BlackRock Inc. (4.12%), Conestoga Capital Advisors LLC (2.98%), Dimensional Fund Advisors LP (2.56%), QV Investors Inc. (1.83%) and Renaissance Technologies LLC (1.49%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, John N Nunnelly, Jona S Raasch, Kevin R Karas and Steven D Jackson. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is National Research's stock price today? One share of NRC stock can currently be purchased for approximately $43.92. How much money does National Research make? National Research (NASDAQ:NRC) has a market capitalization of $1.08 billion and generates $151.57 million in revenue each year. The company earns $31.80 million in net income (profit) each year or $1.21 on an earnings per share basis. How many employees does National Research have? The company employs 511 workers across the globe. Does National Research have any subsidiaries? The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.Read More How can I contact National Research? National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The official website for the company is www.nrchealth.com. The company can be reached via phone at (402) 475-2525 or via fax at 402-475-9061. This page (NASDAQ:NRC) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.